These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24210775)

  • 41. [Evaluation of celioscopic methods in digestive and gynecologic surgery].
    Ann Chir; 1995; 49(1):83-6. PubMed ID: 7741476
    [No Abstract]   [Full Text] [Related]  

  • 42. [Preventive aspects in the indication for gynecologic operations].
    Kyank H
    Zentralbl Gynakol; 1973 Jun; 95(25):833-40. PubMed ID: 4738974
    [No Abstract]   [Full Text] [Related]  

  • 43. [The importance of bacteriological analysis of the cervical canal and the surgically removed tube in preoperative and postoperative treatment].
    Györvári V; Kubinyi J; Kolos A; Ferkó S
    Orv Hetil; 1969 Oct; 110(42):2447-9. PubMed ID: 5358751
    [No Abstract]   [Full Text] [Related]  

  • 44. Risk-reducing salpingo-oophorectomy for BRCA mutation carriers.
    Haldar K; Crawford R
    Maturitas; 2010 Nov; 67(3):290. PubMed ID: 20869823
    [No Abstract]   [Full Text] [Related]  

  • 45. Peritoneal gliomatosis produced by ovarian teratomas.
    Nogales FF; Oliva HA
    Obstet Gynecol; 1974 Jun; 43(6):915-20. PubMed ID: 4829286
    [No Abstract]   [Full Text] [Related]  

  • 46. [Simultaneous operations in emergency surgery].
    Taranenko LD; Bondarev VI; Gazi MR; Klechanovskiĭ GE
    Klin Khir (1962); 1986; (4):39-42. PubMed ID: 3713013
    [No Abstract]   [Full Text] [Related]  

  • 47. The tubal hypothesis of ovarian cancer: caution needed.
    Collins IM; Domchek SM; Huntsman DG; Mitchell G
    Lancet Oncol; 2011 Nov; 12(12):1089-91. PubMed ID: 21868285
    [No Abstract]   [Full Text] [Related]  

  • 48. Occult ovarian cancer at the time of risk-reducing salpingo-oophorectomy.
    Powell CB
    Gynecol Oncol; 2006 Jan; 100(1):1-2. PubMed ID: 16368438
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of tubal reconstructive surgery in the era of assisted reproductive technologies.
    Practice Committee of the American Society for Reproductive Medicine
    Fertil Steril; 2006 Nov; 86(5 Suppl 1):S31-4. PubMed ID: 17055842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation.
    Mahajan NN
    Cancer; 2007 Dec; 110(12):2819; author reply 2819-20. PubMed ID: 17969078
    [No Abstract]   [Full Text] [Related]  

  • 51. Case report of a pelvic-peritoneal tuberculosis presenting as an adnexial mass and mimicking ovarian cancer, and a review of the literature.
    Ilhan AH; Durmuşoğlu F
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):87-9. PubMed ID: 15739822
    [No Abstract]   [Full Text] [Related]  

  • 52. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical management of chronic pelvic pain.
    Parsons LH; Stovall TG
    Obstet Gynecol Clin North Am; 1993 Dec; 20(4):765-78. PubMed ID: 8115090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy.
    ACOG
    Obstet Gynecol; 2008 Jan; 111(1):231-41. PubMed ID: 18165419
    [No Abstract]   [Full Text] [Related]  

  • 55. Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development.
    Leblanc E; Narducci F; Farre I; Peyrat JP; Taieb S; Adenis C; Vennin P
    Gynecol Oncol; 2011 Jun; 121(3):472-6. PubMed ID: 21411127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.
    Rabban JT; Garg K; Crawford B; Chen LM; Zaloudek CJ
    Am J Surg Pathol; 2014 Jun; 38(6):729-42. PubMed ID: 24820399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Abdominal irrigation of the fallopian tubes; clinical use and further results].
    HIRSCH G; WEISS R
    Geburtshilfe Frauenheilkd; 1951 Jul; 11(7):631-7. PubMed ID: 14873060
    [No Abstract]   [Full Text] [Related]  

  • 58. Diagnostic and operative applications of laparoscopy.
    Rosen AD
    Tex Med; 1972 May; 68(5):94-101. PubMed ID: 4260244
    [No Abstract]   [Full Text] [Related]  

  • 59. Tying fallopian tubes to ovarian cancer risk.
    Jenks S
    J Natl Cancer Inst; 2012 Apr; 104(8):578-9. PubMed ID: 22472541
    [No Abstract]   [Full Text] [Related]  

  • 60. New methods of pelviscopy (gynecologic laparoscopy) for myomectomy, ovariectomy, tubectomy and adnectomy.
    Semm K
    Endoscopy; 1979 May; 11(2):85-93. PubMed ID: 156118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.